论文部分内容阅读
目的了解门诊仅接受口服降糖药物治疗的2型糖尿病(T2DM)患者降糖达标现状及糖尿病慢性并发症、合并症的发生情况。方法收集我院门诊仅接受口服降糖药物治疗(3个月以上)的T2DM病例401例,通过问卷调查的方式收集患者血糖、HbA1c值、血压、血脂、自我管理信息、治疗方案、合并症及慢性并发症等情况,评估HbA1c≤6.5%的达标现状及糖尿病慢性并发症、合并症的发生情况。结果血糖控制现状调查显示HbA1c≤6.5%的达标率为17.5%;HbA1c>6.5%组合并心脑血管疾病、慢性并发症的比率明显高于HbA1c≤6.5%组;36.9%患者血糖监测频率≥4次每月,13.7%患者HbA1c监测频率≥4次每年;患者控制饮食、规律运动的比例分别为74.6%、51.6%;大多数患者应用2种及以上降糖药物治疗。结论门诊仅接受口服药物治疗的T2DM患者血糖控制达标率低,血糖控制不良与糖尿病合并症、慢性并发症相关。
Objective To investigate the status of hypoglycemic compliance and chronic complications and complications of outpatients with type 2 diabetes mellitus (T2DM) undergoing oral hypoglycemic treatment only. Methods 401 cases of T2DM cases receiving only oral hypoglycemic drugs (more than 3 months) were collected in our hospital. The patients’ blood glucose, HbA1c, blood pressure, blood lipids, self-management information, treatment regimens, complications and Chronic complications, etc., to assess the status of compliance HbA1c ≤ 6.5% and chronic complications of diabetes, complications of the situation. Results The prevalence of glycemic control showed that the compliance rate of HbA1c≤6.5% was 17.5%, the rate of HbA1c> 6.5% with cardiovascular complications and chronic complications was significantly higher than that of HbA1c≤6.5%, and the frequency of blood glucose monitoring was 36% The monthly frequency of HbA1c surveillance was ≥4 times per year in 13.7% of patients. The rates of dietary and regular exercise control were 74.6% and 51.6% respectively. Most patients were treated with two or more hypoglycemic agents. Conclusion Outpatient T2DM patients undergoing oral drug treatment only have a low rate of glycemic control, and poor glycemic control is associated with diabetic complications and chronic complications.